{
    "2019-10-02": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Novartis (NVS) Announces Data on Asthma Drugs & Kisqali",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Asthma Drugs",
                        "Kisqali",
                        "Data Announcement"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data",
                "features": {
                    "keywords": [
                        "J&J",
                        "Ohio Opioid Lawsuit",
                        "Teligent",
                        "Novartis",
                        "Cosentyx Data"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Bausch shares slide on suit against Novartis unit Sandoz over blockbuster drug patents",
                "features": {
                    "keywords": [
                        "Bausch",
                        "shares slide",
                        "Novartis",
                        "Sandoz",
                        "blockbuster drug patents",
                        "lawsuit"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}